Basal cell carcinoma natural history: Difference between revisions
Jump to navigation
Jump to search
| Line 26: | Line 26: | ||
==Prognosis== | ==Prognosis== | ||
*Prognosis of basal cell carcinoma is usually excellent<ref name="Czarnecki1998">{{cite journal|last1=Czarnecki|first1=D.|title=The prognosis of patients with basal and squamous cell carcinoma of the skin|journal=International Journal of Dermatology|volume=37|issue=9|year=1998|pages=656–658|issn=00119059|doi=10.1046/j.1365-4362.1998.00559.x}}</ref> | *Prognosis of basal cell carcinoma is usually excellent<ref name="Czarnecki1998">{{cite journal|last1=Czarnecki|first1=D.|title=The prognosis of patients with basal and squamous cell carcinoma of the skin|journal=International Journal of Dermatology|volume=37|issue=9|year=1998|pages=656–658|issn=00119059|doi=10.1046/j.1365-4362.1998.00559.x}}</ref><ref name="pmid26449265">{{cite journal |vauthors=Correia de Sá TR, Silva R, Lopes JM |title=Basal cell carcinoma of the skin (part 2): diagnosis, prognosis and management |journal=Future Oncol |volume=11 |issue=22 |pages=3023–38 |date=November 2015 |pmid=26449265 |doi=10.2217/fon.15.245 |url=}}</ref>. | ||
. | |||
*These lesions are typically slow growing, and metastatic disease is a very rare event. | *These lesions are typically slow growing, and metastatic disease is a very rare event. | ||
*BCCs will cause considerable disfigurement by locally destroying skin, cartilage, and even bone. | *BCCs will cause considerable disfigurement by locally destroying skin, cartilage, and even bone. | ||
Revision as of 16:46, 19 February 2019
|
Basal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Basal cell carcinoma natural history On the Web |
|
American Roentgen Ray Society Images of Basal cell carcinoma natural history |
|
Risk calculators and risk factors for Basal cell carcinoma natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saarah T. Alkhairy, M.D.
Overview
Basal cell carcinoma is slow-growing and locally invasive. Common complications of BCC commonly include reccurrence and development of other types of skin cancer. Prognosis is usually excellent, but the tumor is usually locally invasive and may be destructive.
Natural History
- Patients with basal cell carcinoma are often asymptomatic
- Basal cell carcinoma is slow-growing and locally invasive
- The overall risk of metastases is estimated to be less than 0.1%
- The risk of invasion and recurrence is based on size, duration, location and subtype (sclerodermiform/morpheaform and micronodular clinical variants have a higher risk)
- Even without a recurrence, a personal history of basal cell carcinoma increases the risk of developing all types of skin cancers
Complications
Complications of basal cell carcinoma are the following:
- Reccurrence
- Development of other types of skin cancer
- Metastasis
- Jaw cysts (90% by 40 years)[1]
- Ovarian calcification or fibroma (24%)[1]
- Medulloblastoma (5%)[1]
- Cardiac fibroma (3%)[1]
- Cleft palate (5%)[1]
- Ophthalmic complications, such as squint or cataracts (26%)[1]
Prognosis
- Prognosis of basal cell carcinoma is usually excellent[2][3].
- These lesions are typically slow growing, and metastatic disease is a very rare event.
- BCCs will cause considerable disfigurement by locally destroying skin, cartilage, and even bone.
- Recurrence is a issue with basal cell carcinoma.
- Approximately 50% of recurrences are apparent within the first two years.
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 Evans, D G; Ladusans, E J; Rimmer, S; Burnell, L D; Thakker, N; Farndon, P A (1993). "Complications of the naevoid basal cell carcinoma syndrome: results of a population based study". Journal of Medical Genetics. 30 (6): 460–464. doi:10.1136/jmg.30.6.460. ISSN 1468-6244.
- ↑ Czarnecki, D. (1998). "The prognosis of patients with basal and squamous cell carcinoma of the skin". International Journal of Dermatology. 37 (9): 656–658. doi:10.1046/j.1365-4362.1998.00559.x. ISSN 0011-9059.
- ↑ Correia de Sá TR, Silva R, Lopes JM (November 2015). "Basal cell carcinoma of the skin (part 2): diagnosis, prognosis and management". Future Oncol. 11 (22): 3023–38. doi:10.2217/fon.15.245. PMID 26449265.